L
Lykon
Biotech & Life Sciences · Berlin, Germany · Founded 2015
An innovative health care company that provides digital health coaching based on Biomarker analysis MoreLess
Lykon operates in the personalized health and wellness market, offering at-home blood and DNA tests to help individuals optimize their diet and nutrient intake. The company serves health-conscious consumers looking to tailor their dietary and lifestyle choices based on their unique genetic and metabolic profiles. Lykon's business model revolves around selling test kits directly to consumers through their website, as well as offering subscription-based services for ongoing health monitoring and personalized recommendations. Revenue is generated from the sale of these test kits and subscription services. The company leverages advanced biotechnology to provide actionable insights, making it easier for clients to achieve their health and wellness goals.
Keywords: personalized health, at-home tests, blood analysis, DNA analysis, diet optimization, nutrient balance, genetic profiling, health monitoring, biotechnology, wellness.
Talent graph
Lykon's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Lykon's cap table
Sourced from Dealroom's funding and investor records.





Global footprint
Where Lykon has talent and traffic
team presence
Market sentiment
What the market is saying about Lykon
An AI-synthesized read of the highest-engagement posts about Lykon on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lykon on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.